The Service Hospitalier Frédéric Joliot - Contributions to PET chemistry over the years

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 50, Issue 9-10, 2007, Pages 848-866

  Roeda, Dirk ^a   Kuhnast, Bertrand ^a   Hammadi, Akli ^b   Dollé, Frédéric ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

Carbon 11; CEA; Fluorine 18; Service Hospitalier Fr d ric Joliot

Indexed keywords

CARBON; FLUORINE; MOLECULAR IMAGING;

CARBON-11; CEA; DRIVING FORCES; FLUORINE-18; RESEARCH PLATFORMS; SERVICE HOSPITALI FRÉDÉRIC JOLIOT; SHORT-LIVED RADIOISOTOPES;

POSITRON EMISSION TOMOGRAPHY;

CARBON 11; FLUORINE 18; RADIOISOTOPE;

ARTICLE; CHEMISTRY; DIAGNOSTIC IMAGING; FRANCE; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY;

EID: 35948977811     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1420     Document Type: Article

References (241)

1. Comar D, Crouzel C. Bull Infor Sci Techn CEA 1976; 220: 9-18.
2. Comar D, Crouzel C. Radiochem Radioanal Lett 1975; 23: 131-137.
3. Comar D, Crouzel C. Radiochem Radioanal Lett 1976; 27: 307-312.
4. Crouzel C, Petitjean F, Comar D. Radiochem Radioanal Lett 1976; 27: 185-190.
5. Crouzel C, Le Poec C, Jarry E, Knipper R, Comar D. Nucl Instrum Methods 1979; 165: 341-344.
6. Christman D, Crawford EJ, Friedkin M, Wolf AP. Proc Natl Acad Sci USA 1972; 69: 988-992.
7. Comar D, Mazière M, Crouzel C. Synthèse et métabolisme de l'iodométhylate de chlorpromazine. Radiopharmaceuticals and Labelled Compounds, vol. 1. IAEA: Vienna, 1973; 461-469.
8. 11C-chorpromazine in animals. In Radiopharmaceuticals, Subramanian G, Rhodes B, Cooper J, Sodd V (eds). Society of Nuclear Medicine: New York, 1975; 189-204.
9. Marche P, Marazano C, Mazière M, Morgat JL, Llose PDL, Comar D, Fromageot P. Radiochem Radioanal Lett 1975; 21: 53-59.
10. Marazano C, Mazière M, Berger G, Comar D. Int J Appl Radiat Isot 1977; 28: 49-52.
11. Berger G, Mazière M, Knipper R, Prenant C, Comar D. Appl Radiat Isot 1979; 30: 393-399.
12. Berger G, Mazière M, Sastre J, Comar D. J Label Compd Radiopharm 1980; 17: 59-71.
13. Crouzel C, Långström B, Pike VW, Coenen HH. Appl Radiat Isot 1987; 38: 601-603.
14. Crouzel C, Comar D, Berger G, Mazière M, Soussaline F, Todd Pokropek A, Baron JC, Guenard H, Verhas M. IEEE Trans Nucl Sci 1979; NS-26: 2274-2276.
15. Comar D, Zariflan E, Verhas M, Soussaline F, Mazière M, Berger G, Loo H, Cuche H, Kellershohn C, Deniker P. Psychiatry Res 1979; 1: 23-29.
16. Syrota A. Ann Anesthésiol Fr 1980; 21: 621-628.
17. Mazière M, Comar D, Marazano C, Berger G. Eur J Nucl Med 1976; 1: 255-258.
18. Mazière M, Berger G, Masse R, Plummer R, Comar D. The in vivo distribution of carbon-11 labelled (-)-nicotine in animals. A method suitable for use in man. In Electrophysiological Effects of Nicotine, Remond A, Izard C (eds). Elsevier, North-Holland Biomedical Press: Amsterdam, 1979; 31-47.
19. Halldin C, Någren K, Swahn CG, Långström B, Nyback H. Nucl Med Biol 1992; 19: 871-880.
20. Saji H, Magata Y, Yamada Y, Tajima K, Yonekura Y, Konishi J, Ohmomo Y, Yokoyama A. Chem Pharm Bull 1992; 40: 734-736.
21. 11C]nicotine: historical aspects. In Brain Imaging of Nicotine and Tobacco Smoking, Domino EF (ed.). NPP Books: Ann Arbor, MI, 1995; 13-28.
22. Hara T, Kosaka N. Synthesis and application of C-11-nicotine to positron emission tomography: R-isomer for cerebral blood flow mapping and S-isomer for study of Alzheimer's disease. In Brain Imaging of Nicotine and Tobacco, Domino EF (ed.). NPP Books: Ann Arbor, MI, 1995; 29-44.
23. Lundqvist H, Långström B, Nordberg A. Eur J Nucl Med 1997; 24: 825-826.
24. Lundqvist H, Nordberg A, Hartvig P, Långström B. Alz Dis Assoc Disorder 1998; 12: 238-246.
25. Muzic RF, Berridge MS, Friedland RP, Zhu N, Nelson AD. J Nucl Med 1998; 39: 2048-2054.
26. Sihver W, Fasth KJ, Ogren M, Biheved H, Bergström M, Watanabe Y, Långström B. J Neurochem 1998; 71: 1750-1760.
27. Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. Psychopharmacology 2006; 188: 509-520.
28. Dollé F, Dolci L, Valette H, Bottlaender M, Fournier D, Fuseau C, Vaufrey F, Crouzel C. J Label Compd Radiopharm 1996; 38: 1099-1112.
29. Dollé F, Valette H, Bottlaender M, Hinnen F, Vaufrey F, Guenther I, Crouzel C. J Label Compd Radiopharm 1998; 41: 451-463.
30. Dolci L, Dollé F, Valette H, Vaufrey F, Fuseau C, Bottlaender M, Crouzel C. Bioorg Med Chem 1999; 7: 467-479.
31. Dollé F, Dolci L, Valette H, Hinnen F, Vaufrey F, Guenther I, Fuseau C, Coulon C, Bottlaender M, Crouzel C. J Med Chem 1999; 42: 2251-2259.
32. Dollé F, Valette H, Hinnen F, Vaufrey F, Demphel S, Coulon C, Ottaviani M, Bottlaender M, Crouzel C. J Label Compd Radiopharm 2001; 44: 785-795.
33. Roger G, Lagnel B, Rouden J, Besret L, Valette H, Demphel S, Gopisetti JM, Coulon C, Ottaviani M, Wrenn LA, Letchworth SR, Bohme GA, Benavides J, Lasne MC, Bottlaender M, Dollé F. Bioorg Med Chem 2003; 11: 5333-5343.
34. Roger G, Saba W, Valette H, Hinnen F, Coulon C, Ottaviani M, Bottlaender M, Dollé F. Bioorg Med Chem 2006; 14: 3848-3858.
35. Roger G, Hinnen F, Valette H, Saba W, Bottlaender M, Dollé F. J Label Compd Radiopharm 2006; 49: 489-504.
36. Comar D, Cartron JC, Mazière M, Marazano C. Eur J Nucl Med 1976; 1: 11-14.
37. Vaalburg W, Coenen HH, Crouzel C, Elsinga PH, Långström B, Lemaire C, Meyer GJ. Nucl Med Biol 1992; 19: 227-237.
38. Comar D, Saudubray JM, Duthilleul A, Delforge J, Mazière M, Berger G, Charpentier C, Todd Prokopek A. Eur J Pediatr 1981; 136: 13-19.
39. Syrota A, Crouzel M, Sastre J, Prenant C, Kellershohn C. Eur J Nucl Med 1979; 4: 141.
40. Syrota A, Dopngasa M, Cerf M, Paraf A. Gut 1981; 22: 907-915.
41. Syrota A, Collard P, Paraf A. Gut 1983; 24: 637-641.
42. Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, Syrota A. Neurosurgery 1989; 25: 720-728.
43. Straatmann MG, Welch MJ. J Nucl Med 1975; 16: 425-428.
44. Berger G, Mazière M, Prenant C, Sastre J, Comar D. Int J Appl Radiat Isot 1984; 35: 81-83.
45. Pike VW, Halldin C, Crouzel C, Barré L, Nutt DJ, Osman S, Shah F, Turton DR, Waters SL. Nucl Med Biol 1993; 20: 503-525.
46. Comar D, Mazière M, Godot JM, Berger G, Soussaline F, Menini C, Arfel G, Naquet R. Nature 1979; 280: 329-331.
47. Mazière M, Godot JM, Berger G, Prenant C, Comar D. J Radioanal Chem 1980; 56: 229-235.
48. Mazière M, Hantraye P, Prenant C, Sastre J, Comar D. Int J Appl Radiat Isot 1984; 35: 973-976.
49. Halldin C, Stone-Elander S, Thorell JO, Person A, Sedvall G. Appl Radiat Isot 1988; 39: 993-997.
50. Brouillet E, Chavoix C, Khalili-Varasteh M, Bottlaender M, Hantraye P, Yorke JC, Mazière M. Mol Pharmacol 1990; 38: 445-451.
51. Delforge J, Syrota A, Bottlaender M, Varastet M, Loc'h C, Bendriem B, Crouzel C, Brouillet E, Mazière M. J Cereb Blood Flow Metab 1993; 13: 454-468.
52. Delforge J, Pappata S, Millet P, Samson Y, Bendriem B, Jobert A, Crouzel C, Syrota A. J Cereb Blood Flow Metab 1995; 15: 284-300.
53. Okazawa H, Yamauchi H, Sugimoto K, Magata Y, Kudo T, Yonekura Y. J Comp Ass Tom 2004; 28: 428-435.
54. Chavoix C, Hantraye P, Brouillet E, Guibert B, Fukuda H, de la Sayette V, Fournier D, Naquet R, Mazière M. Eur J Pharmacol 1988; 146: 207-214.
55. Brouillet E, Chavoix C, Hantraye P, Kunimoto M, Khalili-Varasteh M, Chevalier P, Frydman A, Gaillot J, Prenant C, Crouzel M, Mazière B, Mazière M. Eur J Pharmacol 1990; 175: 49-55.
56. Brouillet E, Chavoix C, Bottlaender M, Khalili-Varasteh M, Hantraye P, Fournier D, Dodd RH, Mazière M. Brain Res 1991; 557: 167-176.
57. de la Sayette V, Chavoix C, Brouillet E, Hantraye P, Kunimoto M, Khalili-Varasteh M, Guibert B, Prenant C, Mazière M. Exp Brain Res 1991; 83: 397-402.
58. Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS. Ann Neurol 1996; 40: 188-198.
59. Richardson MP, Koepp MJ, Brooks DJ, Duncan JS. Neurology 1998; 51: 485-492.
60. Bouvard S, Costes N, Bonnefoi F, Lavenne F, Mauguiere F, Delforge J, Ryvlin P. Brain 2005; 128: 1330-1343.
61. Krasikova R, Fedorova O, Korsakov M, Någren K, Mazière B, Halldin C. J Label Compd Radiopharm 2000; 43: 613-621.
62. Ryzhikov NN, Seneca N, Krasikova RN, Gomzina NA, Shchukin E, Fedorova OS, Vassiliev DA, Gulyas B, Hall H, Savic I, Halldin C. Nucl Med Biol 2005; 32: 109-116.
63. Camsonne R, Crouzel C, Comar D, Mazière M, Prenant C, Sastre J, Moulin MA, Syrota A. J Label Compd Radiopharm 1984; 21: 985-991.
64. Charbonneau P, Syrota A, Crouzel C, Valois JM, Prenant C, Crouzel M. Circulation 1986; 73: 476-483.
65. Pappata S, Cornu P, Samson Y, Prenant C, Benavides J, Scatton B, Crouzel C, Hauw JJ, Syrota A. J Nucl Med 1991; 32: 1608-1610.
66. Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, Jones T, Kreutzberg GW, Banati RB. Neurology 2000; 55: 1052-1054.
67. Turner MR, Cagnin A, Turkheimer FE, Miller CCJ, Shaw CE. Neurobiol Dis 2004; 15: 601-609.
68. Kropholler MA, Boellaard R, Schuitemaker A, Van Berckel BN, Luurtsema G, Windhorst AD, Lammertsma AA. J Cereb Blood Flow Metab 2005; 25: 842-851.
69. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Neuroimage 2005; 24: 591-595.
70. Gerhard A, Pavese N, Hotton G, Turkheimer F, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ. Neurobiol Dis 2006; 21: 404-412.
71. James ML, Fulton RR Henderson DJ, Eberl S, Meikle SR Thomson S, Allan RD, Dollé F, Fulham MJ, Kassiou M. Bioorg Med Chem 2005; 13: 6188-6194.
72. Thominiaux C, Dollé F, James ML, Bramoulle Y, Boutin H, Besret L, Grégoire MC, Valette H, Bottlaender M, Tavitian B, Hantraye P, Selleri S, Kassiou M. Appl Radiat Isot 2006; 64: 570-573.
73. Thominiaux C, Mattner F, Greguric I, Boutin H, Chauveau F, Kuhnast B, Grégoire MC, Loc'h C, Valette H, Bottlaender M, Hantraye P, Tavitian B, Katsifis A, Dollé F. J Label Compd Radiopharm 2007; 50: 229-236.
74. Mazière M, Comar D, Godot JM, Collard P, Naquet R. Life Sci 1981; 29: 2391-2397.
75. Mazière M, Berger G, Godot JM, Prenant C, Sastre J, Comar D. J Radioanal Chem 1983; 76: 305-309.
76. Syrota A, Paillotin G, Davy JM, Aumont MC. Life Sci 1984; 35: 937-945.
77. Syrota A, Comar D, Paillotin G, Davy JM, Aumont MC, Stulzaft O, Mazière B. Proc Natl Acad Sci USA 1985; 82: 584-588.
78. Delforge J, Janier M, Syrota A, Crouzel C, Vallois JM, Cayla J, Lancon JP, Mazoyer BM. Circulation 1990; 82: 1494-1504.
79. Varastet M, Brouillet E, Chavoix C, Prenant C, Crouzel C, Stulzaft O, Bottlaender M, Cayla J, Mazière B, Mazière M. Eur J Pharmacol 1992; 213: 275-284.
80. Delforge J, Le Guludec D, Syrota A, Bendriem B, Crouzel C, Slama M, Merlet P. J Nucl Med 1993; 34: 981-991.
81. Le Guludec D, Delforge J, Syrota A, Desruennes M, Valette H, Gandjbakhnch I, Merlet P. Circulation 1994; 90: 172-178.
82. Valette H, Deleuze P, Syrota A, Delforge J, Crouzel C, Fuseau C, Loisance D. J Nucl Med 1995; 36: 140-146.
83. Le Guludec D, Cohen-Solal A, Delforge J, Delahaye N, Syrota A, Merlet P. Circulation 1997; 96: 3416-3422.
84. Valette H, Syrota A, Fuseau C. J Nucl Med 1997; 38: 1430-1433.
85. Delahaye N, Dinanian S, Slama MS, Mzabi H, Samuel D, Adams D, Merlet P, Le Guludec D. Eur J Nucl Med 1999; 26: 416-424.
86. Dollé F, Hinnen F, Vaufrey F, Demphel S, Bramoulle Y, Fournier D, Ponchant M, Valette H, Crouzel C. J Label Compd Radiopharm 2001; 44: 337-345.
87. Dollé F, Emond P, Mavel S, Demphel S, Hinnen F, Mincheva Z, Saba W, Valette H, Chalon S, Halldin C, Helfenbein J, Legaillard J, Madelmont JC, Deloye JB, Bottlaender M, Guilloteau D. Bioorg Med Chem 2006; 14: 1115-1125.
88. Chalon S, Hall H, Saba W, Garreau L, Dollé F, Halldin C, Emond P, Bottlaender M, Deloye JB, Helfenbein J, Madelmont JC, Bodard S, Mincheva Z, Besnard JC, Guilloteau D. J Pharmacol Exp Ther 2006; 317: 147-152.
89. Chen P, Kilts C, Camp VM, Ely T, Keil R, Malveaux E, Votaw D, Hoffman JM, Goodman MM. J Label Compd Radiopharm 1999; 42: S400.
90. Emond P, Garreau L, Chalon S, Boazi M, Caillet M, Bricard J, Frangin Y, Mauclaire L, Besnard JC, Guilloteau D. J Med Chem 1997; 40: 1366-1372.
91. Dollé F, Bottlaender M, Demphel S, Emond P, Fuseau C, Coulon C, Ottaviani M, Valette H, Loc'h C, Halldin C, Mauclalre L, Guilloteau D, Mazière B, Crouzel C. J Label Compd Radiopharm 2000; 43: 997-1004.
92. Saba W, Valette H, Schollhorn-Peyronneau MA, Coulon C, Ottaviani M, Chalon S, Dollé F, Emond P, Halldin C, Helfenbein J, Madelmont JC, Deloye JB, Guilloteau D, Bottlaender M. Synapse 2007; 61: 17-23.
93. Jewett DM. Appl Radiat Isot 1992; 43: 1383-1385.
94. Någren K, Müller L, Halldin C, Swahn CG, Lehikoinen P. Nucl Med Biol 1995; 22: 235-239.
95. Någren K, Halldin C, Müller L, Swahn CG, Lehikoinen P. Nucl Med Biol 1995; 22: 965-970.
96. Någren K, Halldin C. J Label Compd Radiopharm 1998; 41: 831-841.
97. Langer O, Någren K, Dollé F, Lundkvist C, Sandell J, Swahn CG, Vaufrey F, Crouzel C, Mazière B, Halldin C. J Label Compd Radiopharm 1999; 42: 1183-1193.
98. Sandell J, Langer O, Larsen P, Dollé F, Vaufrey F, Demphel S, Crouzel C, Halldin C. J Label Compd Radiopharm 2000; 43: 331-338.
99. Langer O, Halldin C, Dollé F, Swahn CG, Olsson H, Karlsson P, Hall H, Sandell J, Lundkvist C, Vaufrey F, Loc'h C, Crouzel C, Mazière B, Farde L. Nucl Med Biol 1999; 26: 509-518.
100. Dollé F, Bramoulle Y, Hinnen F, Fowler JS. J Label Compd Radiopharm 2002; 45: 803-811.
101. Kuhnast B, Valette H, Besret L, Demphel S, Coulon C, Ottaviani M, Guillermier M, Bottlaender M, Dollé F. Nucl Med Biol 2006; 33: 785-795.
102. Boullais C, Oberdorfer F, Sastre J, Prenant C, Crouzel C. J Label Compd Radiopharm 1985; 22: 1081-1086.
103. Roeda D, Dollé F. J Label Compd Radiopharm 2003; 46: 449-458.
104. Roeda D, Crouzel C. Appl Radiat Isot 2001; 54: 935-939.
105. Roeda D, Crouzel C, Dollé F. Radiochim Acta 2004; 92: 329-332.
106. Roeda D, Dollé F. J Label Compd Radiopharm 2006; 49: 295-304.
107. Roeda D, Dollé F, Crouzel C. J Label Compd Radiopharm 1997; 40: 725-726.
108. Roeda D, Sipilä HT, Bramoulle Y, Enas JD, Vaufrey F, Dollé F, Crouzel C. J Label Compd Radiopharm 2002; 45: 37-47.
109. Langer O, Krcal A, Schmid A, Abrahim A, Minetti P, Celona D, Roeda D, Dollé F, Kletter K, Müller M. J Label Compd Radiopharm 2005; 48: 577-587.
110. Berger G, Mazière M, Prenant C, Comar D. Int J Appl Radiat Isot 1980; 31: 577-578.
111. Studenov AR, Berridge MS, Soloviev DV, Matarrese M, Todde S. Nucl Med Biol 1999; 26: 431-435.
112. Kopka K, Law MP, Breyholz HJ, Faust A, Holtke C, Riemann B, Schober O, Schäfers M, Wagner S. Curr Med Chem 2005; 12: 2057-2074.
113. Berger G, Mazière M, Prenant C, Sastre J, Syrota A, Comar D. J Radioanal Chem 1982; 74: 301-306.
114. Berger G, Prenant C, Sastre J, Syrota A, Comar D. Int J Appl Radiat Isot 1983; 34: 1556-1557.
115. Prenant C, Sastre J, Crouzel C, Syrota A. J Label Compd Radiopharm 1987; 24: 227-232.
116. Prenant C, Crouzel C. J Label Compd Radiopharm 1990; 28: 645-651.
117. Roeda D, Crouzel C, van Zanten B. Radiochem Radioanal Lett 1978; 33: 175-178.
118. Roeda D, Westera G. Int J Appl Radiat Isot 1981; 32: 843-845.
119. Baron JC, Comar D, Crouzel C, Roeda D, Mestelan G, Zarifian E, Munari C, Stoffels C, Bancaud J, Chodkiewicz JP, Loo H, Agid Y. Brain regional pharmacokinetics of C-11-labelled di-phenylhydantoin and pimozide in man. In Positron Tomography of the Brain, Heiss WD, Phelps ME (eds). Springer: Berlin, Heidelberg, 1982; 212-224.
120. Baron JC, Roeda D, Munari C, Crouzel C, Chodkiewicz JP, Comar D. Neurology 1983; 33: 580-585.
121. Crouzel C, Mestelan G, Kraus E, Lecomte JM, Comar D. Int J Appl Radiat Isot 1980; 31: 545-548.
122. Baron JC, Comar D, Zarifian E, Crouzel C, Mestelan G, Loo H, Agid Y. An in vivo study of the dopaminergic receptors in the brain of man using 11C-PImOzIdC and positron emission tomography. In Functional Radionuclide Imaging of the Brain, Magistretti PL (ed.). Raven Press: New York, 1983; 337-345.
123. Roeda D, Crouzel C, van der Jagt PJ, van Zanten B, Comar D. Int J Appl Radiat Isot 1980; 31: 549-551.
124. Berridge M, Comar D, Crouzel C, Baron JC. J Label Compd Radiopharm 1983; 20: 73-78.
125. Baron JC, Samson Y, Comar D, Crouzel C, Deniker P, Agid Y. Rev Neurol 1985; 141: 537-545.
126. 2 receptor antagonist. In Cerebral Blood Flow and Metabolism Measurement, Hartmann A, Hoyer S (eds). Springer: Berlin, Heidelberg, 1985; 471-480.
127. Berridge M, Comar D, Crouzel C. Int J Appl Radiat Isot 1983; 34: 1657-1658.
128. Berridge M, Comar D, Roeda D, Syrota A. Int J Appl Radiat Isot 1982; 33: 647-651.
129. Syrota A, Castaing M, Rougemont D, Berridge M, Mazière B, Baron JC, Bousser MG, Pocidalo JJ. Regional tissue pH and oxygen metabolism in human cerebral infarction studied with positron emission tomography. In The Metabolism of the Human Brain Studied with Positron Emission Tomography, Greitz T, Ingvar DH, Widén L (eds). Raven Press: New York, 1985; 285-303.
130. Syrota A, Samson Y, Boullais C, Wajnberg P, Loc'h C, Crouzel C, Mazière B, Soussaline F, Baron JC. J Cereb Blood Flow Metab 1985; 5: 358-368.
131. Landais P, Crouzel C. Appl Radiat Isot 1987; 38: 297-300.
132. Link JM, Krohn KA. J Label Compd Radiopharm 1997; 40: 306-308.
133. Dollé F, Bramoulle Y, Hinnen F, Demphel S, George P, Bottlaender M. J Label Compd Radiopharm 2003; 46: 783-792.
134. Dollé F, Martarello L, Bramoulle Y, Bottlaender M, Gee AD. J Label Compd Radiopharm 2005; 48: 501-513.
135. Boullais C, Crouzel C, Syrota A. J Label Compd Radiopharm 1986; 23: 565-567.
136. Seto M, Syrota A, Crouzel C, Charbonneau P, Vallois JM, Cayla J, Boullais C. J Nucl Med 1986; 27: 949.
137. Delforge J, Syrota A, Lancon JP, Nakajima K, Loc'h C, Janier M, Vallois JM, Cayla J, Crouzel C. J Nucl Med 1991; 32: 739-748.
138. Merlet P, Delforge J, Syrota A, Angevin E, Mazière B, Crouzel C, Valette H, Loisance D, Castaigne A, Dubois-Rande JL. Circulation 1993; 87: 1169-1178.
139. Delforge J, Mesangeau D, Dollé F, Merlet P, Loc'h C, Bottlaender M, Trebossen R, Syrota A. J Nucl Med 2002; 43: 215-226.
140. Hammadi A, Crouzel C. J Label Compd Radiopharm 1991; 29: 681-690.
141. Bernard S, Fuseau C, Schmid L, Milcent R, Crouzel C. Eur J Nucl Med 1996; 23: 150-156.
142. Roeda D, Tavitian B, Coulon C, David F, Dollé F, Fuseau C, Jobert A, Crouzel C. Bioorg Med Chem 1997; 5: 397-403.
143. Dollé F, Valette H, Bramoulle Y, Guenther I, Fuseau C, Coulon C, Lartizien C, Jegham S, George P, Curet O, Pinquier JL, Bottlaender M. Bioorg Med Chem Lett 2003; 13: 1771-1775.
144. Roger G, Lagnel B, Besret L, Bramoulle Y, Coulon C, Ottaviani M, Kassiou M, Bottlaender M, Valette H, Dollé F. Bioorg Med Chem 2003; 11: 5401-5408.
145. Roger G, Dollé F, de Bruin B, Liu X, Besret L, Bramoulle Y, Coulon C, Ottaviani M, Bottlaender M, Valette H, Kassiou M. Bioorg Med Chem 2004; 12: 3229-3237.
146. Bonnot-Lours S, Crouzel C, Prenant C, Hinnen F. J Label Compd Radiopharm 1993; 33: 277-284.
147. Tavitian B, Pappata S, Planas AM, Jobert A, Bonnot-Lours S, Crouzel C, Di Giamberardino L. Neuroreport 1993; 4: 535-538.
148. Planas AM, Crouzel C, Hinnen F, Jobert A, Né F, Di Giamberardino L, Tavitian B. Neuroimage 1994; 1: 173-180.
149. Crouzel C, Hinnen F, Maître E. Appl Radiat Isot 1995; 46: 167-170.
150. Pappata S, Tavitian B, Traykov L, Jobert A, Dalger A, Mangin JF, Crouzel C, Di Giamberardino L. J Neurochem 1996; 67: 876-879.
151. 11C]physostigmme and PET. In Physiological Imaging of the Brain with PET, Gjedde A, Baarsgaard Hansen S, Knudsen GM, Paulsen OB (eds). Academic Press: London, 2000; 273-278.
152. Blomqvist G, Tavitian B, Pappata S, Crouzel C, Jobert A, Doignon I, Di Giamberardino L. J Cereb Blood Flow Metab 2001; 21: 114-131.
153. Pappata S, Blomqvist G, Damier P, Tavitian B, Traykov L, Jobert A, Dubois B, Crouzel C, Di Giamberardino L. Eur J Nucl Med 2001; 28: 1010.
154. Roumenov D, Ricard M, Valette H, Lartizien C, Dollé F, Pinquier J, Curet O, George P, Trebossen R, Bottlaender M. J Nucl Med 2002; 43: 357P.
155. Bottlaender M, Dollé F, Guenther I, Roumenov D, Fuseau C, Bramoulle Y, Curet O, Jegham J, Pinquier JL, George P, Valette H. J Pharmacol Exp Ther 2003; 305: 467-473.
156. Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A. J Pharmacol Exp Ther 2005; 314: 431-436.
157. Crouzel C, Amano R, Fournier D. Appl Radiat Isot 1987; 38: 669-670.
158. Crouzel C, Syrota A. Appl Radiat Isot 1990; 41: 241-242.
159. Roeda D, Crouzel C, Brouillet E, Valette H. Nucl Med Biol 1996; 23: 509-512.
160. Dollé F, Hinnen F, Valette H, Fuseau C, Duval R, Peglion JL, Crouzel C. Bioorg Med Chem 1997; 5: 749-764.
161. Dollé F, Valette H, Hinnen F, Fuseau C, Peglion JL, Crouzel C. Nucl Med Biol 1998; 25: 339-342.
162. Dollé F, Valette H, Hinnen F, Demphel S, Bramoulle Y, Peglion JL, Crouzel C. J Label Compd Radiopharm 2001; 44: 481-499.
163. Brouillet E, Roeda D, Valette H, Fuseau C, Guyot MC, Crouzel C. Eur J Pharmacol Environmental Toxicol Pharmacol Sect 1995; 293: 487-490.
164. Mestelan G, Crouzel C, Cepeda C, Baron JC. Eur J Nucl Med 1982; 7: 379-386.
165. Namavari M, Bishop A, Satyamurthy N, Bida G, Barrio JR. Appl Radiat Isot 1992; 43: 989-996.
166. Dollé F, Demphel S, Hinnen F, Fournier D, Vaufrey F, Crouzel C. J Label Compd Radiopharm 1998; 41: 105-114.
167. Coenen HH, Klatte B, Knoechel A, Schueller M, Stöcklin G. J Label Compd Radiopharm 1986; 23: 455-467.
168. Hamacher FK, Coenen HH, Stöcklin G. J Nucl Med 1986; 27: 235-238.
169. Crouzel C, Comar D. Int J Appl Radiat Isot 1978; 29: 407-408.
170. Oberdorfer F, Crouzel C, Comar D. J Label Compd Radiopharm 1984; 21: 1194-1195.
171. Berridge MS, Crouzel C, Comar D. J Label Compd Radiopharm 1985; 22: 687-694.
172. Crouzel C, Venet M, Irie T, Sanz G, Boullais C. J Label Compd Radiopharm 1988; 25: 403-414.
173. Mazière B, Crouzel C, Venet M, Stulzaft O, Sanz G, Ottaviani M, Séjourné C, Pascal O, Bisserbe JC. Nucl Med Biol 1988; 15: 463-468.
174. Crouzel C, Guillaume M, Barré L, Lemaire C, Pike VW. Nucl Med Biol 1992; 19: 857-870.
175. Blin J, Pappata S, Kiyosawa M, Crouzel C, Baron JC. Eur J Pharmacol 1988; 147: 73-82.
176. Blin J, Sette G, Fiorelli M, Bletry O, Elghozi JL, Crouzel C, Baron JC. J Neurochem 1990; 54: 1744-1754.
177. Blin J, Crouzel C. J Neurochem 1992; 58: 2303-2310.
178. Blin J, Baron JC, Dubois B, Crouzel C, Fiorelli M, Attar-Levy D, Pillon B, Fournier D, Vidailhet M, Agid Y. Brain 1993; 116: 497-510.
179. Chabriat H, Tehindrazanarivelo A, Vera P, Samson Y, Pappata S, Boullais N, Bousser MG. Cephalalgia 1995; 15: 104-108.
180. Vera P, Zilbovicius M, Chabriat H, Amarenco P, Bousser MG, Rancurel G, Samson Y. J Nucl Med 1996; 37: 1976-1981.
181. Massou JM, Trichard C, Attar-Levy D, Feline A, Corruble E, Beauflls B, Martinot JL. Psychopharmacology 1997; 133: 99-101.
182. Trichard C, Paillere-Martinot ML, Attar-Levy D, Blin J, Feline A, Martinet JL. Schizophr Res 1998; 31: 13-17.
183. Trichard C, Paillere-Martinot ML, Attar-Levy D, Recassens C, Monnet F, Martinot JL. Am J Psychiatry 1998; 155: 505-508.
184. Attar-Levy D, Martinot JL, Blin J, Dao-Castellana MH, Crouzel C, Mazoyer B, Poirier MF, Bourdel MC, Aymard N, Syrota A, Feline A. Biol Psychiatry 1999; 45: 180-186.
185. Crouzel C, Venet M, Sanz G, Denis A. J Label Compd Radiopharm 1988; 25: 827-832.
186. Karramkam M, Hinnen F, Bramoulle Y, Jubeau S, Dollé F. J Label Compd Radiopharm 2002; 45: 1103-1113.
187. Karramkam M, Dollé F, Valette H, Besret L, Bramoulle Y, Hinnen F, Vaufrey F, Franklin C, Bourg S, Coulon C, Ottaviani M, Delaforge M, Loc'h C, Bottlaender M, Crouzel C. Bioorg Med Chem 2002; 10: 2611-2623.
188. Langer O, Valette H, Dollé F, Halldin C, Loc'h C, Fuseau C, Coulon C, Ottaviani M, Bottlaender M, Mazière B, Crouzel C. Nucl Med Biol 2000; 27: 233-238.
189. Langer O, Dollé F, Valette H, Halldin C, Vaufrey F, Fuseau C, Coulon C, Ottaviani M, Någren K, Bottlaender M, Mazière B, Crouzel C. Bioorg Med Chem 2001; 9: 677-694.
190. Eskola O, Grönroos T, Bergman J, Haaparanta M, Marjamäki P, Lehikoinen P, Forsback S, Langer O, Hinnen F, Dollé F, Halldin C, Solin O. Nucl Med Biol 2004; 31: 103-110.
191. Horti A, Koren AO, Ravert HT, Musachio JL, Mathews WB, London ED, Dannals RF. J Label Compd Radiopharm 1998; 41: 309-318.
192. Valette H, Bottlaender M, Dollé F, Guenther I, Coulon C, Hinnen F, Fuseau C, Ottaviani M, Crouzel C. Life Sci 1998; 64: L93-L97.
193. Valette H, Bottlaender M, Dollé F, Guenther I, Fuseau C, Coulon C, Ottaviani M, Crouzel C. J Nucl Med 1999; 40: 1374-1380.
194. Valette H, Dollé F, Bottlaender M, Hinnen F, Marzin D. Nucl Med Biol 2002; 29: 849-853.
195. Valette H, Bottlaender M, Coulon C, Ottaviani M, Syrota A. Synapse 2002; 44: 58-59.
196. Bottlaender M, Valette H, Roumenov D, Dollé F, Coulon C, Ottaviani M, Hinnen F, Ricard M. J Nucl Med 2003; 44: 596-601.
197. Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A. J Neurochem 2003; 84: 105-111.
198. Gallezot JD, Bottlaender M, Grégoire MC, Roumenov D, Deverre JR, Coulon C, Ottaviani M, Dollé F, Syrota A, Valette H. J Nucl Med 2005; 46: 240-247.
199. Mitkovski S, Villemagne VL, Novakovic KE, O'Keefe G, Tochon-Danguy H, Mulligan RS, Dickinson KL, Saunder T, Grégoire MC, Bottlaender M, Dollé F, Rowe CC. Nucl Med Biol 2005; 32: 585-591.
200. Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A. Synapse 2005; 56: 217-221.
201. Picard F, Bruel D, Servent D, Saba W, Fruchart-Gaillard C, Schollhorn-Peyronneau MA, Roumenov D, Brodtkorb E, Zuberi S, Gambardella A, Steinborn B, Hufnagel A, Valette H, Bottlaender M. Brain 2006; 129: 2047-2060.
202. +-emitting compounds based on fluorine-18. In Topics in Current Chemistry, Krause W (ed.). Springer: Berlin, Heidelberg, 2002; 201-258.
203. Dollé F. Curr Pharm Des 2005; 11: 3221-3235.
204. Dollé F, Perrio C, Barré L, Lasne M-C, Le Bars D. Actual Chim 2006; 301-302: 93-98.
205. Dollé D, Roeda D, Kuhnast B, Lasne M-C. Fluorine-18 chemistry for molecular imaging with positron emission tomography. Advances in Fluorine Sciences - Fluorine and Health. Elsevier: Amsterdam, 2007; in press.
206. 18F]Fluoropyridines: from conventional radiotracers to the labelling of macromolecules such as proteins and oligonucleotides. In PET Chemistry: The Driving Force in Molecular Imaging, Ernst Schering Research Foundation (ed.). Springer: Berlin, Heidelberg, 2007; 113-157.
207. Dolci L, Dollé F, Jubeau S, Vaufrey F, Crouzel C. J Label Compd Radiopharm 1999; 42: 975-985.
208. Karramkam M, Hinnen F, Vaufrey F, Dollé F. J Label Compd Radiopharm 2003; 46: 979-992.
209. Karramkam M, Hinnen F, Berrehouma M, Hlavacek C, Vaufrey F, Halldin C, McCarron JA, Pike VW, Dollé F. Bioorg Med Chem 2003; 11: 2769-2782.
210. Denis A, Crouzel C. J Label Compd Radiopharm 1989; 27: 1007-1013.
211. Blin J, Denis A, Yamaguchi T, Crouzel C, MacKenzie ET, Baron JC. Neurosci Lett 1991; 121: 183-186.
212. DaSilva JN, Crouzel C, Stulzaft O, Khalili-Varasteh M, Hantraye P. Nucl Med Biol 1992; 19: 167-173.
213. Ponchant M, Varastet M, Hantraye P, Chicheportiche R, Kamenka JM, Crouzel C. Nucl Med Biol 1993; 20: 727-733.
214. Loustau-Then I, Ponchant M, Kamenka JM, Crouzel C. J Label Compd Radiopharm 1996; 38: 299-308.
215. Loustau-Then I, Penchant M, Fuseau C, Kamenka JM, Vignon J, Crouzel C. Nucl Med Biol 1997; 24: 513-518.
216. Ponchant M, Kamenka JM, Crouzel C. J Label Compd Radiopharm 1992; 31: 955-960.
217. Hammadi A, Crouzel C. J Label Compd Radiopharm 1993; 33: 703-710.
218. Dollé F, Hinnen F, Emond P, Mavel S, Mincheva Z, Saba W, Schollhorn-Peyronneau MA, Valette H, Garreau L, Chalon S, Halldin C, Helfenbein J, Legaillard J, Madelmont JC, Deloye JB, Bottlaender M, Guilloteau D. J Label Compd Radiopharm 2006; 49: 687-698.
219. Dollé F, Helfenbein J, Hinnen F, Mavel S, Mincheva Z, Saba W, Schollhorn-Peyronneau MA, Valette H, Garreau L, Chalon S, Halldin C, Madelmont J-C, Deloye J-B, Bottlaender M, Legailliard J, Guilloteau D, Emond P. J Label Compd Radiopharm 2007; in press.
220. Johnström P, Stone-Elander S. J Label Compd Radiopharm 1995; 36: 537-547.
221. Johnström P, Stone-Elander S. Appl Radiat Isot 1996; 47: 401-407.
222. Ogawa M, Hatano K, Oishi S, Kawasumi Y, Fujii N, Kawaguchi M, Doi R, Imamura M, Yamamoto M, Ajito K, Mukai T, Saji H, Ito K. Nucl Med Biol 2003; 30: 1-9.
223. Shiue CY, Wolf AP, Hainfeld JF. J Label Compd Radiopharm 1998; 26: 287-289.
224. de Bruin B, Kuhnast B, Hinnen F, Yaouancq L, Amessou M, Johannes L, Samson A, Boisgard R, Tavitian B, Dollé F. Bioconjugate Chem 2005; 16: 406-420.
225. Janssen KP, Vignjevic D, Boisgard R, Falguieres T, Bousquet G, Decaudin D, Dollé F, Louvard D, Tavitian B, Robine S, Johannes L. Cancer Res 2006; 66: 7230-7236.
226. Kuhnast B, Dollé F, Tavitian B. J Label Compd Radiopharm 2002; 45: 1-11.
227. Hamzavi R, Dollé F, Tavitian B, Dahl O, Nielsen PE. Bioconjugate Chem 2003; 14: 941-954.
228. Kuhnast B, Hinnen F, Hamzavi R, Boisgard R, Tavitian B, Nielsen PE, Dollé F. J Label Compd Radiopharm 2005; 48: 51-61.
229. Dollé F, Hinnen F, Vaufrey F, Tavitian B, Crouzel C. J Label Compd Radiopharm 1997; 39: 319-330.
230. Tavitian B, Terrazzino S, Kuhnast B, Marzabal S, Stettler O, Dollé F, Deverre JR, Jobert A, Hinnen F, Bendriem B, Crouzel C, Di Giamberardino L. Nat Med 1998; 4: 467-471.
231. Marzabal S, Terrazzino S, Kuhnast B, Dollé F, Deverre JR, Jobert A, Crouzel C, Di Giamberardino L, Tavitian B. Nucleos Nucleot 1999; 18: 1731-1733.
232. Kuhnast B, Dollé F, Vaufrey F, Hinnen F, Crouzel C, Tavitian B. J Label Compd Radiopharm 2000; 43: 837-848.
233. Kuhnast B, Dollé F, Terrazzino S, Rousseau B, Loc'h C, Vaufrey F, Hinnen F, Doignon I, Pillon F, David C, Crouzel C, Tavitian B. Bioconjugate Chem 2000; 11: 627-636.
234. Tavitian B, Marzabal S, Boutet V, Kuhnast B, Terrazzino S, Moynier M, Dollé F, Deverre JR, Thierry AR. Pharm Res 2002; 19: 367-376.
235. Kuhnast B, Hinnen F, Boisgard R, Tavitian B, Dollé F. J Label Compd Radiopharm 2003; 46: 1093-1103.
236. Kuhnast B, Klussmann S, Hinnen F, Boisgard R, Rousseau B, Furste JP, Tavitian B, Dollé F. J Label Compd Radiopharm 2003; 46: 1205-1219.
237. Boisgard R, Kuhnast B, Vonhoff S, Younes C, Hinnen F, Verbavatz JM, Rousseau B, Furste J, Wlotzka B, Dollé F, Klussmann S, Tavitian B. Eur J Nucl Med Mol Imag 2005; 32: 470-477.
238. Kuhnast B, de Bruin B, Hinnen F, Tavitian B, Dollé F. Bioconjugate Chem. 2004; 15: 617-627.
239. Viel T, Kuhnast B, Hinnen F, Boisgard R, Tavitian B, Dollé F. J Label Compd Radiopharm 2007; in press.
240. Crouzel C, Séjourné C, Comar D. Int J Appl Radiat Isot 1979; 30: 566-568.
241. Amano R, Crouzel C. Appl Radiat Isot 1986; 37: 541-543.